Causes of Complicated Appendicitis at Referral Hospital (AA)

August 12, 2021 updated by: Badhaasaa, Haramaya Unversity

Predictors of Complicated Appendicitis Among Patients Presented to Public Referral Hospitals in Harari Region: A Case-control Study

The study was conducted on a medical record of previously treated patients for acute appendicitis at HFSUH, Harar, Ethiopia. The study design was case-control with a total sample size of 402.

Study Overview

Status

Completed

Conditions

Detailed Description

The case-control study conducted at HFSUH was proceeded following the university's protocol and after passing institutional ethical review permission.

Study Type

Observational

Enrollment (Actual)

402

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Ethiopia
    • Harari NS
      • Harar, Harari NS, Ethiopia, 251
        • CHMS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

all patients with a diagnosis of acute appendicitis and admitted to a public hospital in Harari regional state.

Description

Inclusion Criteria:

  • patients diagnosed with acute appendicitis

Exclusion Criteria:

  • incidental appendectomy patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients having the predictors of complicated appendicitis.
Time Frame: 1 week
Clinical histories like duration of chief complaint, constipation, vomiting, fever, visiting to lower level clinics, presence of comorbidities were used to assess the factors associated with complicated appendicitis.
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Haramaya Unversity

Investigators

  • Principal Investigator: Badhaasaa Bayissa, MD, HU

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2021

Primary Completion (Actual)

March 31, 2021

Study Completion (Actual)

June 28, 2021

Study Registration Dates

First Submitted

August 5, 2021

First Submitted That Met QC Criteria

August 12, 2021

First Posted (Actual)

August 13, 2021

Study Record Updates

Last Update Posted (Actual)

August 13, 2021

Last Update Submitted That Met QC Criteria

August 12, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IHRERC/005/2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

on reasonable request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complicated Appendicitis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe